The statements below are Rochon Genova’s account of this case. They reflect allegations or the firm’s position and have not been determined by a court unless a settlement or judgment is noted.
Latest update
On June 8, 2007 , the class action was commenced. On March 8, 2017 , the parties reached an agreement to settle. On July 19, 2017 , Justice Belobaba of The Ontario Superior Court of Justice approved the Settlement Agreement for the Oxycontin Class Action. On September 23, 2022 , Chief Justice Popescul of the Saskatchewan Court of King’s Bench released his written decision approving the OxyContin® and OxyNEO® National Settlement Agreement as being fair, reasonable and in the best interest of Class Members. The deadline to submit claims to collect settlement funds was February 27, 2024 .
Source: Rochon Genova
About This Case
The claim, filed with the Ontario Superior Court of Justice, alleges that the Defendants knew or ought to have known that ingesting Oxycontin® leads to drug dependency and addiction. Oxycontin® is a narcotic frequently prescribed as a pain-killer. It was approved for use in Canada in 1996. The serious problems associated with ingesting Oxycontin® are alleged to have been well-known to the Defendants for several years. In May 2007, Purdue Pharma LP and some of its senior executives agreed to pay over $600 million in penalties in the United States for misleading consumers and physicians about the addictive properties of Oxycontin®. Some of those senior executives also pleaded guilty to criminal charges in the United States.
Source: Rochon Genova
Who May Be Eligible
Anyone who was prescribed and ingested OxyContin and/or OxyNEO in Canada between January 1, 1996, and February 28, 2017. Estates of deceased Canadian Oxy users are also eligible to file claims, as are spouses, children, and certain other family members.
Source: Rochon Genova
Disclaimer: This information is sourced from Rochon Genova. It is provided for general information only and does not constitute legal advice. Always verify details with the original source before taking any action.
Legal disclaimer: Information on this page is general in nature and does not constitute legal advice. ClaimBar tracks class action settlements and provides updates. Always seek professional legal advice for your specific circumstances.
Did this page answer your question?